Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Aclaris Therapeutics Inc (NASDAQ: ACRS) closed the day trading at $1.15 up 6.48% from the previous closing price of $1.08. In other words, the price has increased by $6.48 from its previous closing price. On the day, 1.76 million shares were traded. ACRS stock price reached its highest trading level at $1.17 during the session, while it also had its lowest trading level at $1.09.
Ratios:
For a better understanding of ACRS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.99 and its Current Ratio is at 3.99. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On December 23, 2024, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 19 ’24 when Mehra Anand bought 666,666 shares for $2.25 per share. The transaction valued at 1,499,998 led to the insider holds 710,030 shares of the business.
Leonard Braden Michael bought 206,025 shares of ACRS for $256,357 on Aug 05 ’24. The 10% Owner now owns 14,250,000 shares after completing the transaction at $1.24 per share. On Aug 02 ’24, another insider, Leonard Braden Michael, who serves as the 10% Owner of the company, bought 167,544 shares for $1.29 each. As a result, the insider paid 216,400 and bolstered with 14,043,975 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACRS now has a Market Capitalization of 124370200 and an Enterprise Value of 13110644. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.63 while its Price-to-Book (P/B) ratio in mrq is 0.80. Its current Enterprise Value per Revenue stands at 0.7 whereas that against EBITDA is -0.251.
Stock Price History:
The Beta on a monthly basis for ACRS is 0.59, which has changed by -0.049586773 over the last 52 weeks, in comparison to a change of 0.059571505 over the same period for the S&P500. Over the past 52 weeks, ACRS has reached a high of $5.17, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is -37.79%, while the 200-Day Moving Average is calculated to be -39.62%.
Shares Statistics:
Over the past 3-months, ACRS traded about 912.45K shares per day on average, while over the past 10 days, ACRS traded about 978870 shares per day. A total of 107.85M shares are outstanding, with a floating share count of 91.36M. Insiders hold about 15.34% of the company’s shares, while institutions hold 68.53% stake in the company. Shares short for ACRS as of 1743379200 were 6241945 with a Short Ratio of 6.84, compared to 1740700800 on 4764970. Therefore, it implies a Short% of Shares Outstanding of 6241945 and a Short% of Float of 6.92.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
